Genetic variant in APE1 gene promoter contributes to cervical cancer risk

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 4, 2013, Pages 360.e1-360.e7

  Wang, Miaomiao ^a   Chu, Haiyan ^a   Wang, Shizhi ^b   Wang, Meilin ^a   Wang, Wei ^a   Han, Suping ^c   Zhang, Zhengdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apurinic apyrimidinic endonuclease 1; base excision repair pathway; cervical cancer; functional polymorphism; molecular epidemiology

Indexed keywords

APYRIMIDINIC ENDONUCLEASE 1; DEOXYRIBONUCLEASE I; LUCIFERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; CANCER RISK; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSIENT TRANSFECTION; UTERINE CERVIX CANCER;

EID: 84884603647     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.07.010     Document Type: Article

References (39)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. M. Shekari, R.C. Sobti, D.M. Tamandani, K. Malekzadeh, P. Kaur, and V. Suri Association of genetic polymorphism of the DNA base excision repair gene (APE-1 Asp/148 Glu) and HPV type (16/18) with the risk of cervix cancer in north Indian population Cancer Biomark 4 2008 63 71
3. X.W. Jin, J. Cash, and A.W. Kennedy Human papillomavirus typing and the reduction of cervical cancer risk Cleve Clin J Med 66 1999 533 539
4. A.M. Jastreboff, and T. Cymet Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy Postgrad Med J 78 2002 225 228
5. M.H. Schiffman, and P. Castle Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 95 2003 E2
6. F.X. Bosch, M.M. Manos, and N. Munoz Prevalence of human papillomavirus in cervical cancer: a worldwide perspective; international biological study on cervical cancer (IBSCC) study group J Natl Cancer Inst 87 1995 796 802
7. D. DiMaio, and J.B. Liao Human papillomaviruses and cervical cancer Adv Virus Res 66 2006 125 159
8. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
9. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
10. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses IARC Monogr Eval Carcinog Risks Hum 64 1995 1 378
11. J. Basu, M.S. Mikhail, and C.W. Ahn Plasma uric acid levels in women with cervical intraepithelial neoplasia Nutr Cancer 51 2005 25 31
12. P.A. Cerutti, and B.F. Trump Inflammation and oxidative stress in carcinogenesis Cancer Cells 3 1991 1 7
13. N. Munoz, S. Franceschi, and C. Bosetti Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359 2002 1093 1101
14. V. Moreno, F.X. Bosch, and N. Munoz Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study Lancet 359 2002 1085 1092
15. D.C. Skegg Oral contraceptives, parity, and cervical cancer Lancet 359 2002 1080 1081
16. G. Danaei, S. Vander Hoorn, A.D. Lopez, C.J. Murray, and M. Ezzati Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors Lancet 366 2005 1784 1793
17. M. Vessey, R. Painter, and D. Yeates Mortality in relation to oral contraceptive use and cigarette smoking Lancet 362 2003 185 191
18. V.A. Bohr, D.H. Phillips, and P.C. Hanawalt Heterogeneous DNA damage and repair in the mammalian genome Cancer Res 47 1987 6426 6436
19. P. Vineis, G. Talaska, and C. Malaveille DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke Int J Cancer 65 1996 314 316
20. S. Asami, H. Manabe, and J. Miyake Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung Carcinogenesis 18 1997 1763 1766
21. J.K. Wiencke DNA adduct burden and tobacco carcinogenesis Oncogene 21 2002 7376 7391
22. S. Loft, X.S. Deng, J. Tuo, A. Wellejus, M. Sorensen, and H.E. Poulsen Experimental study of oxidative DNA damage Free Radic Res 29 1998 525 539
23. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
24. D.M. Wilson III, and L.H. Thompson Life without DNA repair Proc Natl Acad Sci U S A 94 1997 12754 12757
25. E.C. Friedberg How nucleotide excision repair protects against cancer Nat Rev Cancer 1 2001 22 33
26. R.D. Wood, M. Mitchell, J. Sgouros, and T. Lindahl Human DNA repair genes Science 291 2001 1284 1289
27. B. Demple, and L. Harrison Repair of oxidative damage to DNA: enzymology and biology Annu Rev Biochem 63 1994 915 948
28. S. Mitra, T. Izumi, I. Boldogh, K.K. Bhakat, J.W. Hill, and T.K. Hazra Choreography of oxidative damage repair in mammalian genomes Free Radic Biol Med 33 2002 15 28
29. S. Mitra, T. Izumi, I. Boldogh, K.K. Bhakat, R. Chattopadhyay, and B. Szczesny Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein DNA Repair (Amst) 6 2007 461 469
30. H.E. Krokan, H. Nilsen, F. Skorpen, M. Otterlei, and G. Slupphaug Base excision repair of DNA in mammalian cells FEBS Lett 476 2000 73 77
31. Y. Matsumoto Molecular mechanism of PCNA-dependent base excision repair Prog Nucleic Acid Res Mol Biol 68 2001 129 138
32. J. Chang-Claude, O. Popanda, and X.L. Tan Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients Clin Cancer Res 11 2005 4802 4809
33. F.Y. Chiang, C.W. Wu, and P.J. Hsiao Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma Clin Cancer Res 14 2008 5919 5924
34. C. Li, Z. Hu, and J. Lu Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck Cancer 110 2007 867 875
35. L.B. Chiarini, F.G. Freitas, H. Petrs-Silva, and R. Linden Evidence that the bifunctional redox factor/AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina Cell Death Differ 7 2000 272 281
36. M.S. Bobola, L.S. Finn, and R.G. Ellenbogen Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors Clin Cancer Res 11 2005 7405 7414
37. J. Lu, S. Zhang, and D. Chen Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility FASEB J 23 2009 3459 3469
38. Y.L. Lo, Y.S. Jou, and C.F. Hsiao A polymorphism in the APE1 gene promoter is associated with lung cancer risk Cancer Epidemiol Biomarkers Prev 18 2009 223 229
39. B. Zhou, H. Shan, and Y. Su The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: a meta-analysis based on 37 case-control studies BMC Cancer 11 2011 521